 BILLERICA, Mass.--BUSINESS WIRE--Quanterix Corporation NASDAQ:QTRX, a company digitizing biomarker analysis to advance the science of precision health, today announced a webinar with leading industry experts to discuss neurological advancements related to the ultra-sensitive quantification of pTau181, pTau217, pTau231, and other neurological biomarkers. With several pharmaceutical companies making significant advances towards approval of Alzheimers Disease therapies, this webinar discussio 